What if ambulance and emergency department clinicians could stop bleeding faster?

What if physicians could harness cells' unique capabilities to repair and heal to save lives?

What if doctors could image internal bleeding and avoid invasive surgery?

Next generation platelet-based therapeutics

Revolutionizing Bleeding Treatment

Cellphire Therapeutics focus is to save lives by bringing novel hemostatic products to patients most in need. Our initial product candidates have substantial advantages compared to the current standard of care, liquid stored platelets, which are subject to challenges in availability (due to short shelf life of 3-5 days), efficacy and safety:

  • Stabilizing human cells for extended shelf life with rapid restoration, easy preparation and use
  • Pooling cells from many donors ensuring consistent quality, safety, and scalable production
  • Formulating cell therapies to achieve a desired biological outcome

Cellphire currently has two differentiated products in Phase 2 clinical studies, our freeze-dried platelet-derived hemostat "FPH" (Thrombosomes®), and our Cryopreserved Platelets "CPP".

About our science

Join Our Team

Discover yourself at Cellphire

We are looking for talented, innovative people to join us as we work to save lives by creating transformative, stabilized cellular therapeutics. Learn more about the work we do, our team, and the benefits we have to offer.

Clinical Trials and Research

Current Clinical Trials

Cellphire is actively recruiting study sites for our Phase 2 clinical trial.

Research & Development

We are continually exploring new applications for stabilized cellular therapies.

Want to hear more about our trials and research?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.